Avandia Plaintiffs Must Comply With Lone Pine Order: Judge

Law360, New York (November 19, 2010, 7:38 PM EST) -- As the individual cases in massive multidistrict litigation accusing GlaxoSmithKline PLC of concealing the risks of diabetes medication Avandia move toward trial or resolution, a federal judge has ordered the plaintiffs to produce additional proof of their claims in order to weed out unsubstantiated allegations.

Judge Cynthia M. Rufe of the U.S. District Court for the Eastern District of Pennsylvania granted GSK's motion for a Lone Pine case management order Monday, agreeing with the defendant's argument that the plaintiffs had not provided significant support for their...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.